Effects of Artificial Intelligence Clinical Decision Support Tools on Complications Following Percutaneous Coronary

Karley B Fischer1, Damian N Valencia2, Ananya Reddy3

  • 1Department of Internal Medicine, Kettering Health Main Campus, Kettering, Ohio.

Insights

Artificial intelligence tools significantly reduced contrast-induced acute kidney injury and bleeding after cardiac procedures. AI also decreased patient length of stay, improving outcomes and lowering costs.

Area of Science:

  • Cardiology
  • Nephrology
  • Artificial Intelligence

Background:

  • Percutaneous coronary intervention (PCI) carries risks of contrast-induced acute kidney injury (CI-AKI) and bleeding.
  • These complications increase adverse outcomes, length of stay (LOS), and healthcare costs.
  • AI models can stratify patient risk for PCI complications.

Purpose of the Study:

  • To evaluate the impact of AI clinical decision support tools on CI-AKI and bleeding events post-PCI.
  • To assess the effect of AI on patient length of stay (LOS) following PCI.

Main Methods:

  • Retrospective review of 642 patients undergoing PCI from April 2023 to March 2024.
  • Utilized ePRISM AI tool for patient risk assessment and contrast volume recommendations.
  • Analyzed incidence of CI-AKI, bleeding events, and LOS.

Main Results:

  • CI-AKI incidence decreased from 10% to 2.18% (P < .0001).
  • Bleeding complications reduced from 2.15 to 1.54 events per month.
  • Average LOS decreased from 3.44 to 1.79 days.

Conclusions:

  • AI clinical decision support tools are effective in clinical practice.
  • ePRISM successfully reduced CI-AKI, bleeding, and LOS in PCI patients.
  • AI integration leads to significant improvements in patient outcomes and resource utilization.
Abstract